发明授权
- 专利标题: Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
- 专利标题(中): 法呢基化四氢萘酚作为降血脂药
-
申请号: US995485申请日: 1992-12-23
-
公开(公告)号: US5296508A公开(公告)日: 1994-03-22
- 发明人: Bradley C. Pearce
- 申请人: Bradley C. Pearce
- 申请人地址: NY New York
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: NY New York
- 主分类号: C07C39/23
- IPC分类号: C07C39/23 ; C07C43/215 ; C07C43/23 ; C07C45/67 ; C07C45/68 ; C07C49/747 ; C07C49/753 ; C07C309/65 ; C07C317/18 ; A61K31/215 ; C07C69/017
摘要:
The invention relates to novel farnesylated tetrahydro-naphthalenols, that inhibit HMGR activity which results in a decrease in serum total cholesterol, a decrease in LDL cholesterol levels, and inhibition of LDL oxidation. The farnesylated tetrahydro-naphthalenols of the present invention are thus useful for cholesterol/lipid lowering in cases of hypercholesterolemia, hyperlipidemia, and atherosclerosis.
公开/授权文献
- US6104257A Crystal oscillator with eprom-controlled frequency trim 公开/授权日:2000-08-15